Cancer Policy FDA to increase regulatory flexibility for development of cell and gene therapies January 16, 2026Vol.52 No.02By Jacquelyn Cobb
Cancer Policy OpenAI launches ChatGPT Health to analyze medical records January 16, 2026Vol.52 No.02By Claire Marie Porter
Cancer Policy Federal judge grants preliminary injunction to restore $12M in grants to AAP January 16, 2026Vol.52 No.02By Claire Marie Porter
In Brief The Mark Foundation names 2026 Emerging Leader Award recipients January 16, 2026Vol.52 No.02
In Brief Katie Coleman named senior advisor for translational innovation at OSUCC–James January 16, 2026Vol.52 No.02
In Brief Alex Bates named director for executive communications at the OSUCCC–James January 16, 2026Vol.52 No.02
Clinical Roundup Tecvayli monotherapy demonstrates superior PFS and OS vs. standard of care in MM January 16, 2026Vol.52 No.02
Clinical Roundup Rybrevant leads to anti-tumor activity and durable responses in CRC, phase I/II follow-up results show January 16, 2026Vol.52 No.02
Clinical Roundup Bepirovirsen demonstrates positive results in chronic hepatitis B, phase III trials show January 16, 2026Vol.52 No.02
